Abstract
Diabetes caused wound healing delay is attributed to the enhanced and prolonged inflammation, which is always induced by a large amount of inflammatory mediators secreted by macrophage cells. Therefore, it is urgent to develop a strategy to attenuate macrophage cells-mediated inflammation in diabetic wound treatment. In this study, we fabricated curcumin-loaded chitosan nanoparticles (Cur-CS-NPs) and explored their potential to accelerate diabetic wound healing. The results showed the diabetic model treated by Cur-CS-NPs showed better physical characterizations than control group, manifested by a sustained drug release and efficient cell uptake. Furthermore, we found Cur-CS-NPs could effectively attenuate macrophage-mediated inflammation and enhanced angiogenesis in vitro and in vivo. Taken together, Cur-CS-NPs promote the diabetic wound healing in streptozotocin-induced diabetic rat models.
Get full access to this article
View all access options for this article.
References
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
